Actively Recruiting
Evaluating the Safety and Effectiveness of the VDyne Transcatheter Valve System for Treating Severe Tricuspid Regurgitation
Led by VDyne, Inc. · Updated on 2026-09-21
30
Participants Needed
11
Research Sites
260 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and clinical effectiveness of the VDyne System for treating symptomatic severe tricuspid regurgitation TR, a condition affecting the tricuspid valve of the heart. This study aims to assess both device- and procedure-related risks and improvements in valve function, symptoms, and quality of life in affected adults. The trial is led by VDyne, Inc. and focuses on treatment using a novel transcatheter valve replacement system. The investigational treatment is the VDyne Transcatheter Tricuspid Valve Replacement System, which includes a bioprosthetic valve and delivery tools. The device is implanted through the femoral vein into the native tricuspid valve while the heart is beating, guided by imaging techniques. It is repositionable and fully retrievable during the procedure to optimize placement or allow alternative sizing. The treatment phase includes the implantation procedure followed by monitoring for adverse events and clinical outcomes. Participants will undergo assessments including imaging to measure valve function, symptom evaluation using NYHA class, functional capacity tests like the 6-minute walk, and quality of life questionnaires at baseline and up to one year after implantation. Safety is closely monitored with specific attention to major adverse events within 30 days and up to one year post-procedure. The study spans several years, with ongoing follow-up to evaluate longer-term effects and hospitalizations related to heart failure.
CONDITIONS
Brief Title
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
Research Team
V
Vinny Podichetty
J
Jeya Satheesh
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here